The RECOVERY (Randomized Evaluation of COVID-19 Therapy) trial is a large-scale clinical study designed to identify treatments that may be beneficial for people hospitalized with COVID-19. Initiated in March 2020 by researchers at the University of Oxford, the trial aims to evaluate the efficacy and safety of various therapeutic options for COVID-19 by enrolling thousands of patients from multiple hospitals.
